Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan and Singapore forge biomaterials deal:

This article was originally published in Clinica

Executive Summary

The Japanese National Institute for Materials Science and the National University of Singapore last month signed memorandum to collaborate in the field of biomaterials research. Under the agreement, both sides will exchange information and share technology for the designing and processing of biomaterials. The aim is to commercialise new products for advanced medical treatment. The memorandum is part of the Japan-Singapore Economic Agreement, concluded in January 2002, contained within the New Age Partnership, which also includes a bilateral trade agreement, reports Japan Chemical Week.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT065943

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel